Literature DB >> 22446432

Signs and symptoms of temporomandibular dysfunction in fibromyalgic patients.

Byanka P Fraga1, Emanuella B Santos, Jader P Farias Neto, José C Macieira, Lucindo J Quintans, Alexandre S C Onofre, Josimari M De Santana, Paulo Ricardo Saquete Martins-Filho, Leonardo R Bonjardim.   

Abstract

OBJECTIVE: The objective of this study was to determine the frequency of signs and symptoms of temporomandibular disorder (TMD) in fibromyalgic patients.
METHODS: Sixty subjects of both sexes (mean age, 49.2 ± 13.8 years) with fibromyalgia (FM) diagnosis were included in this study. All patients were examined by a calibrated investigator to identify the presence of TMD using the Research Diagnostic Criteria for TMD.
RESULTS: The most common signs (A) and symptoms (B) reported by FM patients were (A) pain in the masticatory muscles (masseter, 80%; posterior digastric, 76.7%), pain in the temporomandibular joint (83.3%), and 33.3% and 28.3%, respectively, presented joint sounds when opening and closing the mouth; (B) headache (97%) and facial pain (81.7%). In regard to the classic triad for the diagnosis of the TMD, it was found that 35% of the FM patients presented, at the same time, pain, joint sounds, and alteration of the mandibular movements. It was verified that myofascial pain without limitation of mouth opening was the most prevalent diagnosis (47%) for the RDC subgroup I. For the subgroup II, the disk displacement with reduction was the most prevalent diagnosis (21.6%). For the subgroup III, 36.7% of the subjects presented osteoarthritis.
CONCLUSIONS: Thus, there is a high prevalence of signs and symptoms of TMD in FM patients, indicating the need for an integrated diagnosis and treatment of these patients, which suggest that the FM could be a medium- or long-term risk factor for the development of TMD.

Entities:  

Mesh:

Year:  2012        PMID: 22446432     DOI: 10.1097/SCS.0b013e31824cd81a

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  7 in total

1.  Perceived helpfulness of treatments for myofascial TMD as a function of comorbid widespread pain.

Authors:  Vivian Santiago; Karen G Raphael
Journal:  Clin Oral Investig       Date:  2019-01-08       Impact factor: 3.573

2.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: Definitions, Similarities, and Differences.

Authors:  Benjamin H Natelson
Journal:  Clin Ther       Date:  2019-02-20       Impact factor: 3.393

3.  Effects of exercise training and photobiomodulation therapy (EXTRAPHOTO) on pain in women with fibromyalgia and temporomandibular disorder: study protocol for a randomized controlled trial.

Authors:  Mariana Moreira da Silva; Regiane Albertini; Ernesto Cesar Pinto Leal-Junior; Paulo de Tarso Camillo de Carvalho; José Antonio Silva; Sandra Kalil Bussadori; Luis Vicente Franco de Oliveira; Cezar Augusto Souza Casarin; Erinaldo Luiz Andrade; Danilo Sales Bocalini; Andrey Jorge Serra
Journal:  Trials       Date:  2015-06-04       Impact factor: 2.279

4.  Evidence of Signs and Symptoms of Craniomandibular Disorders in Fibromyalgia Patients.

Authors:  Massimo Corsalini; Di Venere Daniela; Rapone Biagio; Stefanachi Gianluca; Laforgia Alessandra; Pettini Francesco
Journal:  Open Dent J       Date:  2017-02-14

Review 5.  Animal Models of Temporomandibular Disorder.

Authors:  Ting Xiang; Zhuo-Ying Tao; Li-Fan Liao; Shuang Wang; Dong-Yuan Cao
Journal:  J Pain Res       Date:  2021-05-26       Impact factor: 3.133

6.  Coadministration of Resveratrol and Rice Oil Mitigates Nociception and Oxidative State in a Mouse Fibromyalgia-Like Model.

Authors:  Caroline Peres Klein; Marcos Rodrigues Cintra; Nancy Binda; Danuza Montijo Diniz; Marcus Vinicius Gomez; Andre Arigony Souto; Alessandra Hubner de Souza
Journal:  Pain Res Treat       Date:  2016-03-16

7.  Myogenic temporomandibular disorders: Clinical systemic comorbidities in a female population sample.

Authors:  M de-Pedro-Herráez; J Mesa-Jiménez; C Fernández-de-Las-Peñas; J-L de-la-Hoz-Aizpurua
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.